MarginsXMarginsX
Home › Markets › Health Care › TMCI

Treace Medical Concepts Inc. (TMCI)

TMCI trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.42
-16.13% on the day
Market cap
$289.8M
Micro cap
Revenue · 2025
$212.7M
+1.6% on 2024
Net income · 2025
-$59.0M
-27.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/0001193125-26-079167-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTMCI on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001630627
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inFL

Financials · 2025

LineValue
Revenue$212.7M
Net income-$59.0M
Operating income-$54.2M
Net margin-27.7%
Operating margin-25.5%
Revenue growth+1.6%
Cash$10.7M
Total assets$190.6M
P/E (computed)Net income was not positive
P/S (computed)1.4×

Warning signs

Cash runway
10.7 months
$7.8M cash at September 30, 2026
Share count, 1 year
+2.9%
2025-10-31 to 2026-10-30 · +6.3% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$1.5M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$7.8M cash; operating cash flow -$2.2M a quarter.Report 2026-09-30
Shares outstanding65,559,597 (2026-10-30); 63,718,073 a year earlier; 61,675,861 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton LLP, Jacksonville, Florida, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.5M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$48.3M-$12.6M-$3.3M$7.8M$60.0M$203.3M10-Q 2026-11-06
Q2 2026
2026-06-30
$45.4M-$15.9M-$4.7M$12.6M$59.2M$205.3M10-Q 2026-08-07
Q1 2026
2026-03-31
$47.2M-$18.0M$7.2M$9.5M$57.6M$207.3M10-Q 2026-05-08
Q4 2025
2025-12-31
$62.5M-$9.4M-$8.0M$10.7M$57.3M$212.7M10-K 2026-02-27
Q3 2025
2025-09-30
$50.2M-$16.3M-$9.1M$7.7M$55.3M$218.9M10-Q 2026-11-06
Q2 2025
2025-06-30
$47.4M-$17.4M-$3.0M$8.1M$54.6M$213.8M10-Q 2026-08-07
Q1 2025
2025-03-31
$52.6M-$15.9M$4.2M$13.4M$53.4M$210.8M10-Q 2026-05-08
Q4 2024
2024-12-31
$68.7M-$501K-$4.2M$11.3M$53.3M$209.4M10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52023-02-09
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-06
Latest proxyDEFA14A2026-04-06

Source: SEC EDGAR submissions feed, 447 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+30.8%
1 month+28.5%
3 months+16.9%
Year to date+115.1%
1 year+67.8%
From 52-week high-1.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M
OFIXOrthofix Medical Inc. Common Stock (DE)$6.80-5.16%$277.2M
NPCENeuropace Inc.$7.97+5.42%$274.6M
SSIISS Innovations International Inc.$1.35-18.67%$270.7M
PROFProfound Medical Corp.$7.34-1.08%$268.8M
CLPTClearPoint Neuro Inc.$8.30-2.12%$266.1M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M
EMBCEmbecta Corp.$6.25-3.25%$354.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier